4-{3-nitrophenyl}-2-methyl-N-(2-methylphenyl)-5-oxo-1,4,5,6,7,8-hexahydro-3-quinolinecarboxamide

Request For Quotation
4-{3-nitrophenyl}-2-methyl-N-(2-methylphenyl)-5-oxo-1,4,5,6,7,8-hexahydro-3-quinolinecarboxamide Suppliers list
Company Name: Shanghai Yifei Biotechnology Co. , Ltd.  
Tel: 021-65675885 18964387627
Email: customer_service@efebio.com
Company Name: RD International Technology Co., Limited  
Tel: 18024082417
Email: market@ubiochem.com
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
Company Name: Shanghai Amole Biotechnology Co., Ltd.  
Tel: 13370042665 18916960931
Email: 2596183085@qq.com
Company Name: Guangzhou Ruidi Biotechnology Co., Ltd.  
Tel: 020-82099279 18988941402
Email: sales@ubiochem.com

4-{3-nitrophenyl}-2-methyl-N-(2-methylphenyl)-5-oxo-1,4,5,6,7,8-hexahydro-3-quinolinecarboxamide manufacturers

  • GPR41 agonist-1
  • GPR41 agonist-1 pictures
  • $99.00
  • 2026-04-22
  • CAS:506417-09-0
  • Purity: 98.40%
  • Supply Ability: 10g
4-{3-nitrophenyl}-2-methyl-N-(2-methylphenyl)-5-oxo-1,4,5,6,7,8-hexahydro-3-quinolinecarboxamide Basic information
Product Name:4-{3-nitrophenyl}-2-methyl-N-(2-methylphenyl)-5-oxo-1,4,5,6,7,8-hexahydro-3-quinolinecarboxamide
Synonyms:4-{3-nitrophenyl}-2-methyl-N-(2-methylphenyl)-5-oxo-1,4,5,6,7,8-hexahydro-3-quinolinecarboxamide;GPR41 agonist-1
CAS:506417-09-0
MF:C24H23N3O4
MW:417.45712
EINECS:
Product Categories:
Mol File:506417-09-0.mol
4-{3-nitrophenyl}-2-methyl-N-(2-methylphenyl)-5-oxo-1,4,5,6,7,8-hexahydro-3-quinolinecarboxamide Structure
4-{3-nitrophenyl}-2-methyl-N-(2-methylphenyl)-5-oxo-1,4,5,6,7,8-hexahydro-3-quinolinecarboxamide Chemical Properties
form Solid
color Light yellow to yellow
Safety Information
MSDS Information
4-{3-nitrophenyl}-2-methyl-N-(2-methylphenyl)-5-oxo-1,4,5,6,7,8-hexahydro-3-quinolinecarboxamide Usage And Synthesis
UsesGPR41 agonist-1 (compound 9) is a potent GPR41 agonist. GPR41 agonist-1 can be used for researching insulin-related disorders[1].
References[1] James N. Leonard, et al. Gpr41 and modulators thereof for the treatment of insulin-related disorders. WO2006052566A2.
4-{3-nitrophenyl}-2-methyl-N-(2-methylphenyl)-5-oxo-1,4,5,6,7,8-hexahydro-3-quinolinecarboxamide Preparation Products And Raw materials
Tag:4-{3-nitrophenyl}-2-methyl-N-(2-methylphenyl)-5-oxo-1,4,5,6,7,8-hexahydro-3-quinolinecarboxamide(506417-09-0) Related Product Information
N-(2,5-dichlorophenyl)-4-(furan-2-yl)-2-methyl-5-oxo-4,6,7,8-tetrahydro-1H-quinoline-3-carboxamide SCO-267 4-Methoxy-N-(2,4,6-triMethylphenyl)benzenesulfonaMide, 97% TUG 891 N-(4-butylphenyl)-4-fluorobenzenesulfonamide AMG 837 (calciuM hydrate)